TY - JOUR
T1 - Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains
AU - D'Urzo, Nunzia
AU - Martinelli, Manuele
AU - Pezzicoli, Alfredo
AU - De Cesare, Virginia
AU - Pinto, Vittoria
AU - Margarit, Immaculada
AU - Telford, John Laird
AU - Maione, Domenico
AU - Melin, P.
AU - Decheva, A.
AU - Petrunov, B.
AU - Kriz, P.
AU - Berner, R.
AU - Büchele, A.
AU - Hufnagel, M.
AU - Kunze, M.
AU - Creti, R.
AU - Badassari, L.
AU - Berardi, A.
AU - Orefici, G.
AU - Granger, J. R.
AU - De La Rosa Fraile, M.
AU - Afshar, B.
AU - Efstratiou, A.
PY - 2014/4
Y1 - 2014/4
N2 - Streptococcus agalactiae, also known as group B Streptococcus (GBS), is a primary colonizer of the anogenital mucosa of up to 40% of healthy women and an important cause of invasive neonatal infections worldwide. Among the 10 known capsular serotypes, GBS type III accounts for 30 to 76% of the cases of neonatal meningitis. In recent years, the ability of GBS to form biofilm attracted attention for its possible role in fitness and virulence. Here, a new in vitro biofilm formation protocol was developed to guarantee more stringent conditions, to better discriminate between strong-, low-, and non-biofilm-forming strains, and to facilitate interpretation of data. This protocol was used to screen the biofilm-forming abilities of 366 GBS clinical isolates from pregnant women and from neonatal infections of different serotypes in relation to medium composition and pH. The results identified a subset of isolates of serotypes III and V that formed strong biofilms under acidic conditions. Importantly, the best biofilm formers belonged to serotype III hypervirulent clone ST-17. Moreover, the abilities of proteinase K to strongly inhibit biofilm formation and to disaggregate mature biofilms suggested that proteins play an essential role in promoting GBS biofilm initiation and contribute to biofilm structural stability.
AB - Streptococcus agalactiae, also known as group B Streptococcus (GBS), is a primary colonizer of the anogenital mucosa of up to 40% of healthy women and an important cause of invasive neonatal infections worldwide. Among the 10 known capsular serotypes, GBS type III accounts for 30 to 76% of the cases of neonatal meningitis. In recent years, the ability of GBS to form biofilm attracted attention for its possible role in fitness and virulence. Here, a new in vitro biofilm formation protocol was developed to guarantee more stringent conditions, to better discriminate between strong-, low-, and non-biofilm-forming strains, and to facilitate interpretation of data. This protocol was used to screen the biofilm-forming abilities of 366 GBS clinical isolates from pregnant women and from neonatal infections of different serotypes in relation to medium composition and pH. The results identified a subset of isolates of serotypes III and V that formed strong biofilms under acidic conditions. Importantly, the best biofilm formers belonged to serotype III hypervirulent clone ST-17. Moreover, the abilities of proteinase K to strongly inhibit biofilm formation and to disaggregate mature biofilms suggested that proteins play an essential role in promoting GBS biofilm initiation and contribute to biofilm structural stability.
UR - http://www.scopus.com/inward/record.url?scp=84896052551&partnerID=8YFLogxK
U2 - 10.1128/AEM.03627-13
DO - 10.1128/AEM.03627-13
M3 - Article
C2 - 24487536
AN - SCOPUS:84896052551
SN - 0099-2240
VL - 80
SP - 2176
EP - 2185
JO - Applied and Environmental Microbiology
JF - Applied and Environmental Microbiology
IS - 7
ER -